Bill And Melinda Gates Foundation Bill And Melinda Gates Foundation [Member] Bill And Melinda Gates Foundation [Member] Business Acquisition [Axis] Business Acquisition [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Microchips Biotech, Inc. Microchips Biotech, Inc. [Member] Microchips Biotech, Inc. [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Going Concern Liquidity [Policy Text Block] Liquidity Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Gain on early termination of lease Gain (Loss) on Termination of Lease Gain (Loss) on Termination of Lease Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Additional potential grant funding Additional Potential Funding Related To Grant Award Additional Potential Funding Related To Grant Award Satisfaction of contingent consideration Asset Acquisition, Consideration Transferred, Contingent Consideration Accrued clinical expense Accrued Clinical Expense, Current Accrued Clinical Expense, Current Warrants exercised (in shares) Number Of Common Stock Warrants Exercised Number of common stock warrants exercised. Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] License And Collaboration Agreement License And Collaboration Agreement [Member] License And Collaboration Agreement [Member] Amended And Restated Two Thousand Fourteen Stock Incentive Plan Amended And Restated Two Thousand Fourteen Stock Incentive Plan [Member] Amended And Restated Two Thousand Fourteen Stock Incentive Plan [Member] Milestone payment paid in common stock Milestone Payments, Contingent Amount Milestone payments, contingent amount. Weighted- Average Remaining Contractual Life (Years) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Roll Forward Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term roll forward. Statistical Measurement [Domain] Statistical Measurement [Domain] Depreciation Depreciation Stock options exercised (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of authorized shares, period increase Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Number of Shares, Period Increase (Decrease) Hammock Pharmaceuticals, Inc. Hammock Pharmaceuticals, Inc. [Member] Hammock Pharmaceuticals, Inc. [Member] Pear Tree Pharmaceuticals, Inc. Pear Tree Pharmaceuticals, Inc. [Member] Pear Tree Pharmaceuticals, Inc. Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Other Current Assets Other Current Assets [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Federal Domestic Tax Authority [Member] Indemnification Obligations Guarantees, Indemnifications and Warranties Policies [Policy Text Block] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Prepaid insurance expense Prepaid Insurance Equity Component Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Grant, DARE-FRT1 Grant, DARE-PTB1 [Member] Grant, DARE-PTB1 Current year - increases Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Leased Properties Lessee, Operating Leases [Text Block] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Related Party [Domain] Related Party [Domain] Plan Name [Axis] Plan Name [Axis] Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain] Settlement of contingent closing consideration liability with stock issuance in connection with acquisition of business Noncash or Part Noncash Acquisition, Common Stock Issued for Settlement of Contingent Consideration Liability Noncash or Part Noncash Acquisition, Common Stock Issued for Settlement of Contingent Consideration Liability Supplemental disclosure of non-cash investing and financing activities: Supplemental Cash Flow Information [Abstract] Forfeited (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of operating segments Number of Operating Segments Plan Name [Domain] Plan Name [Domain] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Outstanding, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Warrant, exercise price, decrease Warrant, Exercise Price, Decrease Regular Repurchase (in shares) Regular Repurchase, Common Stock Issuable Regular Repurchase, Common Stock Issuable Award Type [Axis] Award Type [Axis] Operating lease assets Operating Lease, Right-Of-Use Asset, Noncurrent Operating Lease, Right-Of-Use Asset, Noncurrent Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Current portion of lease liabilities Operating Lease, Liability, Current Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Related Party Transaction Related Party Transaction [Domain] Cost, maintenance Cost, Maintenance Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Receivables [Abstract] Receivables [Abstract] 2018 ATM Sales Agreement 2018 At The Market Sales Agreement [Member] 2018 At The Market Sales Agreement Document Annual Report Document Annual Report Legal Entity [Axis] Legal Entity [Axis] Total liabilities Liabilities Operating lease weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Payment to be received upon termination without cause Employment Agreement, Salary Payment Received Upon Termination Without Cause Employment Agreement, Salary Payment Received Upon Termination Without Cause Issuance of common stock, net of issuance costs Stock Issued During Period, Value, New Issues Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Sales Milestones Sales Milestones [Member] Sales Milestones [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Risks and Uncertainties [Abstract] Grant, DARE-FRT1 Grant, DARE-FRT1 [Member] Grant, DARE-FRT1 Payment to be received upon termination for cause or for good reason Employment Agreement, Salary Payment Received Upon Termination for Cause or Good Reason Employment Agreement, Salary Payment Received Upon Termination for Cause or Good Reason Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Research and development agreement, commitment, amount Research and Development Agreement, Commitment, Amount Research and Development Agreement, Commitment, Amount Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Net proceeds from issuance of common stock Net Proceeds From Issuance Of Common Stock And Warrants Net Proceeds From Issuance Of Common Stock And Warrants Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities [Member] Upon Achieving Certain Commercial Milestones Upon Achieving Certain Commercial Milestones [Member] Upon Achieving Certain Commercial Milestones [Member] Product and Service [Domain] Product and Service [Domain] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Entity Shell Company Entity Shell Company Accrued expenses Increase (Decrease) in Accrued Liabilities Prior year - (reductions) Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Concentration Risk [Table] Concentration Risk [Table] 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Aggregate commission rate Percentage Of Aggregate Commission Percentage of aggregate commission. Equity issued in consideration of acquisition (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Proceeds from warrant exercises Proceeds from Warrant Exercises Subsequent Event Subsequent Event [Member] Accrued development expense Accrued Development Expense, Current Accrued Development Expense, Current Document Period End Date Document Period End Date CRADA CRADA [Member] CRADA Deemed dividend from trigger of down round provision feature Deemed Dividend From Trigger Of Round Down Provision Feature Deemed Dividend From Trigger Of Round Down Provision Feature Business development Business Development Prepaid Expenses Other Current Assets [Text Block] Total assets Assets Upon Achieving Certain Clinical And Regulatory Development Milestones Upon Achieving Certain Clinical And Regulatory Development Milestones [Member] Upon Achieving Certain Clinical And Regulatory Development Milestones [Member] Income Statement Location [Axis] Income Statement Location [Axis] Schedule of Accounts Payable and Accrued Expenses Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Accrued expenses Accrued Liabilities, Current Exercised (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Accrued compensation and benefits Employee-related Liabilities, Current Sales based milestones amount Milestone Payments, Contingent Amount, Sales Based Milestones Amount Milestone Payments, Contingent Amount, Sales Based Milestones Amount Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Loss before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders' equity Stockholders' Equity Attributable to Parent [Abstract] Customer [Axis] Customer [Axis] Summary of Assumptions Used in Black-Scholes Option-Pricing Model for Stock Options Granted to Employees, and Non-Employee Directors Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Increase (decrease) in operating lease liability Increase (Decrease) in Operating Lease Liability Summary of Components of Loss from Continuing Operations Before Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Equity Award [Domain] Award Type [Domain] Warrants exercised (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Bayer Healthcare License Agreement Bayer Healthcare License Agreement [Member] Bayer Healthcare License Agreement [Member] Gain on extinguishment of note payable Gain on extinguishment of note payable and accrued interest Gain (Loss) on Extinguishment of Debt Options exercisable, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Australian Taxation Office Australian Taxation Office [Member] Schedule of Other Non-Current Assets Schedule of Other Assets, Noncurrent [Table Text Block] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Entity Registrant Name Entity Registrant Name Issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Prepaid insurance, long-term portion Prepaid Insurance Noncurrent Prepaid insurance noncurrent. Subsequent Events Subsequent Events [Text Block] Supplier Concentration Risk Supplier Concentration Risk [Member] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Entity Address, City or Town Entity Address, City or Town Leases [Abstract] Leases [Abstract] Operating expenses Operating Expenses [Abstract] Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Principles of Consolidation Consolidation, Policy [Policy Text Block] Minimum Minimum [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Accrued indemnification provisions Accrued Indemnification Provisions Accrued indemnification provisions. Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Unamortized stock-based compensation expense Deferred Compensation Share-Based Arrangements, Liability, Current and Noncurrent Asset acquisition, contingent consideration, beginning balance Asset acquisition, contingent consideration, ending balance Contingent consideration Asset Acquisition, Contingent Consideration Asset Acquisition, Contingent Consideration Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Auditor Name Auditor Name Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Net operating loss carryforwards Operating Loss Carryforwards Trading Symbol Trading Symbol Entity File Number Entity File Number Research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Warrants Expiring on April 4, 2026 Warrants Expiring On April Four Two Thousand Twenty Six [Member] Warrants expiring on april four two thousand twenty six. Deferred license revenue Contract with Customer, Liability, Noncurrent Research and development Research and Development Expense Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and contingencies. Prior year - additions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Merger Agreement Merger Agreement [Member] Merger Agreement Other Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent Research Credit Carryforwards Research Tax Credit Carryforward [Member] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Options vested and expected to vest, ending (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Use of Estimates Use of Estimates, Policy [Policy Text Block] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Accounts payable Increase (Decrease) in Accounts Payable Basis of Presentation and Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and contingencies. Concentration risk percentage Concentration Risk, Percentage Subsequent Events [Abstract] Subsequent Events [Abstract] Total revenue Revenues Working capital increase Working Capital Increase (Deficit) Working Capital Increase (Deficit) Accounting Standards Update 2017-11 Accounting Standards Update 2017-11 [Member] Prepaid clinical expense Prepaid Clinical Expense Prepaid Clinical Expense Income Taxes Income Tax Disclosure [Text Block] Exercise price (in usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Offering expenses Offering Expenses Offering Expenses Loss per common share - basic (in usd per share) Earnings Per Share, Basic Loan under Paycheck Protection Program Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received Major Vendor Major Vendor [Member] Major Vendor Concentration Risk Type [Domain] Concentration Risk Type [Domain] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent 2014 Employee Stock Purchase Plan Two Thousand And Fourteen Employee Stock Purchase Plan [Member] Two thousand and fourteen employee stock purchase plan. Prepaid expenses Total prepaid expenses Prepaid Expense, Current Research credit carryforwards Tax Credit Carryforward, Amount Other Deferred Tax Assets, Other Entity Interactive Data Current Entity Interactive Data Current Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Other non-current assets Other Assets, Miscellaneous, Noncurrent Amortized weighted average period Weighted Average Amortization Period Weighted Average Amortization Period Accumulated Deficit Retained Earnings [Member] Accrued license fee expense Accrued License Expense, Current Accrued License Expense, Current Cash balance of financial institutions insured by federal deposits insurance corporation Cash, FDIC Insured Amount Common stock Common Stock [Member] Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Project Project [Domain] Income Taxes Income Tax, Policy [Policy Text Block] Health coverage to be received upon termination without cause Employment Agreement, Health Benefits Coverage Received Upon Termination Without Cause Employment Agreement, Health Benefits Coverage Received Upon Termination Without Cause Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Statement [Table] Statement [Table] SST Strategic Science And Technologies D Limited Liability Company And Strategic Science Technologies Limited Liability Company [Member] Strategic Science and Technologies-D, LLC and Strategic Science Technologies, LLC. Change in control of company, termination without cause or resignation for good reason, period Employment Agreement, Change In Control Of Company, Termination Without Cause Or Resignation For Good Reason Employment Agreement, Change In Control Of Company, Termination Without Cause Or Resignation For Good Reason, Period Renewal term of operating lease Lessee, Operating Lease, Renewal Term Current Assets Assets, Current [Abstract] Lease liabilities long-term Operating Lease, Liability, Noncurrent Research and development credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards, Research Statistical Measurement [Axis] Statistical Measurement [Axis] Related Party Transaction Related Party Transaction [Axis] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Milestone payments Research And Development, Milestone Payment Research and development milestone payment. Equity Components Equity Components [Axis] Capitalized research and development costs Deferred Tax Assets Capitalized Research And Development Cost Deferred Tax Assets Capitalized Research And Development Cost Deferred grant funding Deferred Grant Funding, Current Deferred Grant Funding, Current Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Options exercisable, ending (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Segment Reporting Segment Reporting, Policy [Policy Text Block] Expired (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Document Fiscal Year Focus Document Fiscal Year Focus Period of insufficient cash and liquidity requirements Period of Insufficient Cash and Liquidity Requirements Period of Insufficient Cash and Liquidity Requirements Tax Credit Carryforward Tax Credit Carryforward [Axis] Statement [Line Items] Statement [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Non-cash loss on settlement of contingent liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Assignment Agreement Assignment Agreement [Member] Assignment Agreement [Member] Right-of-use asset Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Auditor Firm ID Auditor Firm ID Options vested and expected to vest, ending (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Document Transition Report Document Transition Report Local Phone Number Local Phone Number Purchase agreement Deferred Offering Costs Significant Accounting Policies [Table] Significant Accounting Policies [Table] Significant accounting policies. Summary of Stock Option Activity for 2015 Plan and Current Plan and Related Information Share-Based Payment Arrangement, Option, Activity [Table Text Block] Loss from operations Operating Income (Loss) License fee expense License Fee Expense License Fee Expense Receivable for expenses eligible for reimbursement Receivable For Expenses Eligible For Reimbursement Receivable For Expenses Eligible For Reimbursement Stock compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost State State and Local Jurisdiction [Member] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax provision Income Tax Expense (Benefit) Prepaid expenses Increase (Decrease) in Prepaid Expense Valuation allowance Deferred tax valuation allowance Deferred Tax Assets, Valuation Allowance Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Income Statement [Abstract] Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Public Float Entity Public Float Prepaid legal and professional expenses Prepaid Professional Expense Prepaid Professional Expense Additional Paid-in Capital Additional Paid-in Capital [Member] Licensing Agreements Licensing Agreements [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Health coverage to be received upon termination for cause or for good reason Employment Agreement, Health Benefits Coverage Received Upon Termination for Cause or Good Reason Employment Agreement, Health Benefits Coverage Received Upon Termination for Cause or Good Reason Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Vendor Concentration Concentration Risk Disclosure [Text Block] DARE-LARC1 DARE-LARC1 [Member] DARE-LARC1 Clinical And Regulatory Milestones Clinical And Regulatory Milestones [Member] Clinical And Regulatory Milestones [Member] Other Assets, Noncurrent Disclosure [Abstract] Other Assets, Noncurrent Disclosure [Abstract] Expected life in years Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Exercise of Options Outstanding Exercise Of Options Outstanding [Member] Exercise of options outstanding. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Total accrued expenses Accounts Payable and Accrued Liabilities, Current Operating lease, incremental borrowing rate, prime rate Operating Lease, Incremental Borrowing Rate, Prime Rate Operating Lease, Incremental Borrowing Rate, Prime Rate Common stock: $0.0001 par value, 240,000,000 and 120,000,000 shares authorized, 84,825,481 and 83,944,119 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively Common stock, value, issued Common Stock, Value, Issued Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Upon Reaching Certain Worldwide Net Sales Milestones Upon Reaching Certain Worldwide Net Sales Milestones [Member] Upon reaching certain worldwide net sales milestones. Decrease in operating lease right-of-use asset Increase (Decrease) In Operating Lease Right-of-Use Asset Increase (Decrease) In Operating Lease Right-of-Use Asset Issuance of common stock in connection with milestone payment Stock Issued During Period, Value, Milestone Payment Stock Issued During Period, Value, Milestone Payment Options exercisable, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Upon Achieving Certain Development Milestones Upon Achieving Certain Development Milestones [Member] Upon Achieving Certain Development Milestones [Member] Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation adjustments Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign License fee, agreement retention, minimum required amount to be received License Fee, Agreement Retention, Minimum Required Amount To Be Received License Fee, Agreement Retention, Minimum Required Amount To Be Received Exercise of Warrants Outstanding Exercise Of Warrants Outstanding [Member] Exercise of warrants outstanding. Issuance of common stock from the exercise of warrants Adjustments to Additional Paid in Capital, Warrant Issued Current Liabilities Liabilities, Current [Abstract] Proceeds from the exercise of stock options Proceeds from Stock Options Exercised Net loss to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Common stock, shares issued (in shares) Common Stock, Shares, Issued Initial payment Grants Receivable Options vested and expected to vest, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Concentration Risk [Line Items] Concentration Risk [Line Items] Maximum potential milestone payments Maximum Potential Milestone Payments Maximum Potential Milestone Payments Deposits Deposits Assets, Noncurrent Defined contribution plan, employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Proceeds from the exercise of common stock warrants Proceeds From Issuance Of Common Stock And Warrants Proceeds from issuance of common stock and warrants. Income Statement Location [Domain] Income Statement Location [Domain] Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Operating lease cost Operating Lease, Cost MBI MBI [Member] MBI Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Catalent and MilanaPharm Catalent and MilanaPharm [Member] Catalent and MilanaPharm Cash flow from operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Potential annual license maintenance fee payments, thereafter Potential Annual License Maintenance Fee Payments, Thereafter Potential Annual License Maintenance Fee Payments, Thereafter Entity Current Reporting Status Entity Current Reporting Status Other non-current assets Total other non-current assets Other Assets, Noncurrent Operating loss carryforwards not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Options exercisable, ending (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Estimated tax incentive Estimated Tax Incentive Estimated Tax Incentive Other Non-Current Assets Other Assets Noncurrent Disclosure [Text Block] Other assets noncurrent disclosure. Federal statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Project Project [Axis] Counterparty Name [Axis] Counterparty Name [Axis] Stock options outstanding (in shares) Outstanding beginning balance (in shares) Outstanding ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Stock compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code State income tax, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Licensed Product or Process for Vaginal or Urological Use Licensed Product or Process for Vaginal or Urological Use [Member] Licensed Product or Process for Vaginal or Urological Use Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property and equipment, net Property, Plant and Equipment, Net Operating lease, payments Operating Lease, Payments Stock Options Share-Based Payment Arrangement, Option [Member] Other non-current assets Increase (Decrease) in Other Noncurrent Assets Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Square feet of office space Net Rentable Area Stock options exercised Stock Issued During Period, Value, Stock Options Exercised Other income Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Expiration Date Class Of Warrant Or Rights Warrants Expiration Date Class of warrant or rights warrants expiration date. Common stock, shares authorized (in shares) Common Stock, Shares Authorized License And Collaboration Revenues License And Collaboration Revenues [Member] License And Collaboration Revenues Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Total operating expenses Operating Expenses Maximum Maximum [Member] Percentage of royalty rate Percentage Of Royalty Rate Percentage of royalty rate. Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Grant Awards Grant [Member] Two Thousand Twenty Two Stock Incentive Plan Two Thousand Twenty Two Stock Incentive Plan [Member] Two Thousand Twenty Two Stock Incentive Plan Juniper Pharmaceuticals, Inc. Juniper Pharmaceuticals, Inc. [Member] Juniper Pharmaceuticals, Inc. [Member] Cash and Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total current assets Assets, Current Deferred financing costs Deferred Offering Costs, Unamortized Portion Deferred Offering Costs, Unamortized Portion Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Operating lease, right-of-use asset, statement of financial position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Entity Small Business Entity Small Business Schedule of Common Stock Outstanding Warrant to Purchase Shares Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Deferred grant funding Increase (Decrease) In Deferred Grant Funding Increase (Decrease) In Deferred Grant Funding Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Revenues [Abstract] Revenues [Abstract] Payments to stockholders' representative in business combination Payments to Stockholders' Representative in Business Combination Payments to Stockholders' Representative in Business Combination Schedule of Financial Assets and Liabilities Remeasured on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Risks and Uncertainties Risks And Uncertainties [Policy Text Block] Risks and uncertainties Net operating loss carryforwards expiration year Operating Loss Carryforwards Expiration Period Operating loss carryforwards expiration period. Grant, ADARE-204 and ADARE-214 Grant, ADARE-204 and ADARE-214 [Member] Grant, ADARE-204 and ADARE-214 Asset Acquisition, Contingent Consideration, Current Asset Acquisition, Contingent Consideration, Current Asset Acquisition, Contingent Consideration, Current Outstanding, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Title of 12(b) Security Title of 12(b) Security Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Purchase Agreement Purchase Agreement [Member] Purchase Agreement Change in control of company, termination for cause or for good reason Employment Agreement, Change in Control of Company, Termination for Cause or Good Reason Employment Agreement, Change in Control of Company, Termination for Cause or Good Reason Schedule of Reconciliation of the Beginning and Ending Amount of Uncertain Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Class of Stock [Line Items] Class of Stock [Line Items] Total operating lease liabilities Operating Lease, Liability Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Granted (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Notes payable including accrued interest Notes Payable, Current, Plus Accrued Interest Notes Payable, Current, Plus Accrued Interest Accounts payable Accounts Payable, Current Income Tax Authority Income Tax Authority [Axis] Options vested and expected to vest, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Other receivables Increase (Decrease) in Other Receivables Auditor Location Auditor Location Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Entity Filer Category Entity Filer Category Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value Roll Forward Share based compensation arrangement by share based payment award options outstanding aggregate intrinsic value. Stock-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies Commitments and Contingencies Outstanding beginning balance (in usd per share) Outstanding ending balance (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price License License [Member] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] DARE-LBT DARE-LBT [Member] DARE-LBT Research credit carryforwards expiration year Tax Credit Carryforward Expiration Period Tax credit carry forward expiration period. Preferred stock issued Preferred Stock, Value, Issued Letter of credit related to lease of real property Letters of Credit Outstanding, Amount General and administrative General and Administrative Expense [Member] Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Common stock reserved for issuance (in shares) Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Leases Lessee, Leases [Policy Text Block] Issuance of common stock in connection with milestone payment (in shares) Stock Issued During Period, Shares, Milestone Payment Stock Issued During Period, Shares, Milestone Payment Level 3 Fair Value, Inputs, Level 3 [Member] Entity Voluntary Filers Entity Voluntary Filers Audit Information [Abstract] Audit Information Annual percentage increase in outstanding number of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum MilanaPharm MilanaPharm [Member] MilanaPharm [Member] Stock-based Compensation Share-Based Payment Arrangement [Text Block] Milestone payments, contingent amount payable, net Milestone Payments, Contingent Amount Payable, Net Milestone Payments, Contingent Amount Payable, Net Upfront license fee paid Upfront License Fee, Amount Paid Upfront License Fee, Amount Paid Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Warrants Expiring On February 15, 2023 Warrants Expiring On February Fifteen Two Thousand Twenty Three [Member] Warrants Expiring On February Fifteen Two Thousand Twenty Three [Member] Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Total liabilities and stockholders' equity Liabilities and Equity Summary of Major Components of Company's Deferred Tax Assets Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Related Party [Axis] Related Party [Axis] Organization, Consolidation and Presentation of Financial Statements [Abstract] Total deferred tax assets Deferred Tax Assets, Gross Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Research credit carryforward, subject To expiration Tax Credit Carry Forward, Subject To Expiration Tax Credit Carry Forward, Subject To Expiration Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Accrued interest or penalties recorded related to uncertain tax positions Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Less: accreted interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Loss per common share - diluted (in usd per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Upon Achieving Certain Clinical Development, Regulatory And Commercial Milestones Upon Achieving Certain Clinical Development, Regulatory And Commercial Milestones [Member] Upon Achieving Certain Clinical Development, Regulatory And Commercial Milestones Recognized offering expenses Payments of Stock Issuance Costs Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Concentration Risk Type [Axis] Concentration Risk Type [Axis] Hennepin License Agreement Hennepin License Agreement [Member] Hennepin License Agreement Total current liabilities Liabilities, Current Grant Awards Grant Award [Text Block] Grant Award [Text Block] NICHD NICHD [Member] NICHD 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two First commercial sale amount Milestone Payments, Contingent Amount, First Commercial Sale Amount Milestone Payments, Contingent Amount, First Commercial Sale Amount Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Unrecognized tax benefits Beginning uncertain tax benefits Ending uncertain tax benefits Unrecognized Tax Benefits Shares issued in satisfaction of milestone payments associated with milestones achieved (in shares) Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued Operating loss carryforward, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Amount Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Permanent differences Effective Income Tax Rate Reconciliation, Permanent Differences Effective income tax rate reconciliation, permanent differences. Future Minimum Lease Payment Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Income Tax Authority Income Tax Authority [Domain] Upon Achievement Of Specified Development And Regulatory Milestones Upon Achievement Of Specified Development And Regulatory Milestones [Member] Upon achievement of specified development and regulatory milestones. Product and Service [Axis] Product and Service [Axis] Deferred tax assets, increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount State tax rate change Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Defined contribution plan, employer matching contributions Defined Contribution Plan, Employer Discretionary Contribution Amount Equity [Abstract] Equity [Abstract] Subsequent Event [Table] Subsequent Event [Table] Other receivables Other Receivables, Net, Current Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Entity Tax Identification Number Entity Tax Identification Number Options to purchase number of outstanding shares of common stock (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Estimated fair value of warrants Estimated Fair Value Of Warrants Recorded In Equity Estimated Fair Value Of Warrants Recorded In Equity Unremitted earnings Unremitted Earnings Unremitted earnings. Grant funding recognized during period Grant Funding Recognized During Period Grant Funding Recognized During Period Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Lincoln Park Lincoln Park [Member] Lincoln Park Non-cash operating lease cost Non-Cash Lease Expense Non-Cash Lease Expense Difference Between Provision for Income Taxes (Benefit) and the Amount Computed by Applying U.S. Federal Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Asset Acquisition, Contingent Consideration, Rollforward [Abstract] Asset Acquisition, Contingent Consideration, Rollforward [Abstract] Asset Acquisition, Contingent Consideration, Rollforward Entity Central Index Key Entity Central Index Key Measurement Frequency [Axis] Measurement Frequency [Axis] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Strategic Agreements Collaborative Arrangement Disclosure [Text Block] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Credits recorded to research and development expense for costs related to award Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred Other accruals Other Accrued Liabilities, Current Summary of Common Stock Reserved for Future Issuance Schedule Of Common Stock Reserved For Future Issuance [Table Text Block] Schedule of common stock reserved for future issuance Entity [Domain] Entity [Domain] Type of Adoption [Domain] Accounting Standards Update [Domain] City Area Code City Area Code Accrued legal and professional Accrued Professional Fees, Current General and administrative General and Administrative Expense Assets Assets [Abstract] Deferred financing costs Debt Issuance Costs, Noncurrent, Net Purchase obligation Purchase Obligation Commitments and Contingencies Commitments Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] ADVA Tec Agreement A D V A Tec Agreement [Member] ADVA Tec agreement. Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Issuance of common stock from the exercise of warrants (in shares) Adjustments To Additional Paid In Capital, Common Stock And Warrants Issued, Shares Adjustments To Additional Paid In Capital, Common Stock And Warrants Issued, Shares Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Weighted-average fair value of options granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value April 2021 ATM Sales Agreement April 2021 At The Market Sales Agreement [Member] April 2021 At The Market Sales Agreement Shares underlying outstanding warrants (in shares) Class of Warrant or Right, Outstanding Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Research and development Research and Development Expense [Member] Registration payment arrangement, maximum potential consideration Registration Payment Arrangement, Maximum Potential Consideration Amount awarded for grant Proceeds From Award Of Grant Proceeds From Award Of Grant Operating right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Organon Organon [Member] Organon Payment of additional consideration in business combination Payment of Additional Consideration in Business Combination Payment of Additional Consideration in Business Combination Customer [Domain] Customer [Domain]